XML 30 R11.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Measurements
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements
4.
Fair Value Measurements
The Company measures and reports its cash equivalents, restricted cash, warrant liabilities
and securities issuance obligation 
at fair value. The following table sets forth the fair value of the Company’s financial assets and liabilities measured on a recurring basis by level within the fair value hierarchy:
 
   
December 31, 2019
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
   
(in thousands)
 
Financial Assets
     
Money market funds
  $146,240   $   $   $146,240 
Restricted money market funds
   300            300 
Total financial assets
  $146,540   $   $   $146,540 
Financial Liabilities
                    
Warrant liabilities
  $   $   $45,935   $45,935 
Securities issuance obligation
           10,485    10,485 
Total financial liabilities
  $   $   $56,420   $56,420 
 
   
December 31, 2018
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
   
(in thousands)
 
Financial Assets
  
 
 
 
Money market funds
  
$
105,224
 
  
$
—  
 
  
$
—  
 
  
$
105,224
 
Restricted money market funds
  
 
300
 
  
 
—  
 
  
 
—  
 
  
 
300
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total financial assets
  
$
105,524
 
  
$
—  
 
  
$
—  
 
  
$
105,524
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Money market funds and restricted money market funds are measured at fair value on a recurring basis using quoted prices and are classified as a Level 1 input.
The Company’s warrant liabilities and securities issuance obligation contain unobservable inputs that reflected the Company’s own assumptions in which there is little, if any, market activity at the measurement date. Accordingly, the Company’s warrant liabilities and securities issuance obligation are measured at fair value on a recurring basis using unobservable inputs at each reporting period. The warrant liabilities and securities issuance obligation are classified as Level 3 inputs. These liabilities are shown as current liabilities on the balance sheet as they are deemed more probable than not by management to be settled within one year.
 
The fair values of the Series A and Series B warrants are estimated using the Black-Scholes option-pricing model. The expected terms represent the periods that the warrants are expected to be outstanding. The risk-free interest rates are based on the U.S. Constant Maturity treasury curve commensurate with the time to expiry. The expected dividend is zero as the Company has not paid nor does it anticipate paying any dividends on its common stock in the foreseeable future. The expected volatilities are estimated by backsolving to volatility implied in the transaction price. Discount for lack of marketability is dependent on the restriction period and the estimated volatility during the period.
The fair value of the warrant issuance obligation is estimated using the Black-Scholes option-pricing model. The expected term represents the period that the underlying warrant is expected to be outstanding from the time the issuance obligation arose. The risk-free interest rate is based on the U.S. Constant Maturity treasury curve commensurate with the time to expiry. The expected dividend is zero as the Company has not paid nor does it anticipate paying any dividends on its common stock in the foreseeable future. The expected volatility is estimated by backsolving to volatility implied in the transaction price. The fair value of the common stock issuance obligation is estimated based on the fair value of the underlying common stock. Discount for lack of marketability is dependent on the restriction period and the estimated volatility during the period.
The assumptions used in calculating the estimated fair values at the end of the reporting period represent the Company’s best estimate. However, inherent uncertainties are involved. If factors or assumptions change, the estimated fair values could be materially different.
At November 13, 2019, the Company estimated the fair values of the financial liabilities using the following assumptions:
 
 
  
Series A 
Warrant
 
 
Series B 
Warrant
 
 
Warrant Issuance
Obligation
 
 
Common Stock
Issuance Obligation
 
Expected term (in years)
  
 
5.2
 
 
 
2.3
 
 
 
5.2
 
 
 
N/A
 
Expected volatility
  
 
43
%
 
 
88
%
 
 
43
 
 
N/A
 
Risk-free interest rate
  
 
1.70
%
 
 
1.64
%
 
 
1.70
 
 
N/A
 
Expected dividend yield
  
 
%
 
 
%
 
 
 
 
N/A
 
Discount for lack of marketability
  
 
30
%
 
 
30
%
 
 
32
 
 
32
At December 31, 2019, the Company remeasured these liabilities to their fair values using the following assumptions:
 
 
 
  
Series A 
Warrant
 
 
Series B 
Warrant
 
 
Warrant Issuance
Obligation
 
 
Common Stock
Issuance Obligation
 
Expected term (in years)
  
 
5.1
 
 
 
2.2
 
 
 
5.1
 
 
 
N/A
 
Expected volatility
  
 
43
 
 
88
 
 
43
 
 
N/A
 
Risk-free interest rate
  
 
1.69
 
 
1.59
 
 
1.70
 
 
N/A
 
Expected dividend yield
  
 
—  
%
 
 
—  
%
 
 
—  
%
 
 
N/A
 
Discount for lack of marketability
  
 
25
%
 
 
25
%
 
 
25
%
 
 25
%
 
The following table provides a summary of changes in the estimated fair values of the Company’s Level 3 financial liabilities, which are measured at fair value on a recurring basis using unobservable inputs:
 
 
  
Series A 
Warrant
Liability
 
  
Series B 
Warrant
Liability
 
  
Warrant 
Issuance
Obligation
 
  
Common Stock
Issuance
 
Obligation
 
  
Total
 
 
  
(in thousands)
 
Balance, December 31, 2018
  
$
—  
 
  
$
—  
 
  
$
—  
 
  
$
—  
 
  
$
—  
 
Issuance of warrants
  
 
17,133
 
  
 
7,876
 
  
 
—  
 
  
 
—  
 
  
 
25,009
 
Securities issuance obligation
  
   
  
   
  
 
1,543
 
  
 
4,903
 
  
 
6,446
 
Changes in fair value
  
 
15,483
 
  
 
5,443
 
  
 
1,493
 
  
 
2,546
 
  
 
24,965
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Balance, December 31, 2019
  
$
32,616
 
  
$
13,319
 
  
$
3,036
 
  
$
7,449
 
  
$
56,420
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
The warrant liabilities will increase or decrease each reporting period based on fluctuations of the fair value of the underlying common stock until such time these financial liabilities are no longer considered derivative instruments, or the earlier of settlement and expiration of warrants. The change in the fair value of warrant liabilities for each presented period is recognized as a component of other income (expense), net in the consolidated statements of operations.
The securities issuance obligation will increase or decrease each reporting period based on fluctuations of the fair value of the underlying common stock until such time the securities are issued. The change in fair values of securities issuance obligation is recognized as research and development expense in the consolidated statement of operations.
There were no transfers between Levels 1, 2 or 3 during the years ended December 31, 2019 and 2018.